Skinvisible (SKVI) Total Liabilities (2010 - 2026)
Skinvisible's (SKVI) quarterly Total Liabilities came in at $10.9 million in Q2 2026, up 10.22% year-over-year from $9.9 million in Q2 2025, and up 2.44% quarter-over-quarter from $10.6 million in Q1 2026.
Analysis
Skinvisible (SKVI) Total Liabilities (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Total Liabilities across 17 years of filings, most recently posting $10.9 million for Q2 2026.
- In Q2 2026, Total Liabilities rose 10.22% year-over-year to $10.9 million; the TTM figure through Jun 2026 stood at $10.9 million (up 10.22% YoY), while the FY2025 annual figure was $10.4 million, up 10.75% from the prior year.
- Total Liabilities came in at $10.9 million for Q2 2026 at Skinvisible, up from $10.6 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $10.9 million in Q2 2026 to a low of $5.8 million in Q1 2022.
- Average Total Liabilities over 5 years is $8.9 million, with a median of $9.4 million recorded in 2024.
- Year-over-year, Total Liabilities soared 43.82% in 2023 and grew 1.22% in 2025.
- Over 5 years, Total Liabilities stood at $6.9 million in 2022, then surged by 33.37% to $9.2 million in 2023, then gained by 2.13% to $9.4 million in 2024, then rose by 10.75% to $10.4 million in 2025, then grew by 4.99% to $10.9 million in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $10.9 million in Q2 2026, $10.6 million in Q1 2026, and $10.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 23.74 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 115.64 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 69.15 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 1.72 Bn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 1.53 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 819.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 10.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.91 Mn |
| Mar 31, 2026 | 10.65 Mn |
| Dec 31, 2025 | 10.39 Mn |
| Sep 30, 2025 | 10.14 Mn |
| Jun 30, 2025 | 9.90 Mn |
| Mar 31, 2025 | 9.63 Mn |
| Dec 31, 2024 | 9.38 Mn |
| Sep 30, 2024 | 10.02 Mn |
| Jun 30, 2024 | 9.74 Mn |
| Mar 31, 2024 | 9.47 Mn |
| Dec 31, 2023 | 9.19 Mn |
| Sep 30, 2023 | 8.90 Mn |
| Jun 30, 2023 | 8.63 Mn |
| Mar 31, 2023 | 8.36 Mn |
| Dec 31, 2022 | 6.89 Mn |
| Sep 30, 2022 | 6.52 Mn |
| Jun 30, 2022 | 6.14 Mn |
| Mar 31, 2022 | 5.81 Mn |
| Dec 31, 2021 | 5.64 Mn |
| Sep 30, 2021 | 5.52 Mn |